25 SEPTEMBER NEW ZEALAND GAZETTE

3245

Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name

(if any)
--- | --- | --- | ---
Ramipril 1.25 mg, 2.5 mg, 5 mg, 10 mg | Tablets | Hoechst AG., Frankfurt (Main), Germany | Ramace
Pantoprazole sodium sesquihydrate 45.1 mg equivalent to 40 mg pantoprazole | Tablet, enteric coated | Byk Gulden Lomberg Chemische Fabrik GmbH., Konstanz, Germany and Oranienburger Pharmawerk GmbH., Oranienburg, Germany | Somac
Nisoldipine 10 mg, 20 mg, 30 mg, 40 mg | Tablet, modified release | Bayer AG., Leverkusen, Germany | Syscor CC
Valaciclovir hydrochloride 556 mg, 1112 mg equivalent to 500 mg, 1000 mg valaciclovir | Tablets, film coated | Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom | Valaciclovir
Valaciclovir hydrochloride 556 mg equivalent to 500 mg valaciclovir | Tablets, film coated | Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom and Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom | Valtrex
Valaciclovir hydrochloride 1112 mg equivalent to 1000 mg valaciclovir | Tablets, film coated | Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom | Valtrex
Ondansetron hydrochloride dihydrate 2 mg/mL in 2 mL, 4mL | Injection, ampoules | Glaxo Wellcome Australia Limited, Boronia, Victoria, Australia | Zofran
Lansoprazole 15 mg, 30 mg | Capsules | Lederle Laboratories, Cyanamid of Great Britain Limited, Gosport, Hampshire, United Kingdom and Wyeth Medica Ireland, Little Connell, Newbridge, County Kildare, Eire | Zoton
Cetirizine hydrochloride 10 mg | Tablet | Laboratori UCB SpA., Pianezza, Italy and UCB Pharma S.A., Chemin du Foriest, Braine-l’Alleud, Brussels, Belgium | Zyrtec
Cetirizine hydrochloride 1 mg/mL in 75 mL | Solution, oral | Laboratori UCB SpA., Pianezza, Italy and UCB Pharma S.A., Chemin du Foriest, Braine-l’Alleud, Brussels, Belgium | Zyrtec
Cetirizine hydrochloride 10 mg/mL in 10 mL | Solution, oral drops | Laboratori UCB SpA., Pianezza, Italy and UCB Pharma S.A., Chemin du Foriest, Braine-l’Alleud, Brussels, Belgium | Zyrtec

Dated this 19th day of September 1997.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go6737

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto:

Schedule

Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name

(if any)
--- | --- | --- | ---
Aciclovir 25 mg/mL in 10 mL, 20 mL | Solution for infusion, vial | David Bull Laboratories Limited, Mulgrave North, Victoria, Australia | Aciclovir Intravenous Infusion
Brimonidine tartrate 2 mg/mL in 2.5 mL, 5 mL, 10 mL | Solution, ophthalmic (eye drops) | Allergan America, Hormigueros, Puerto Rico | Alphagan
Dolasetron mesilate 25 mg, 50 mg, 100 mg, 200 mg | Tablet, film coated | Marion Merrell Dow Pharmaceuticals Inc., Cincinnati, Ohio, United States of America | Anzemet
Dolasetron mesilate 20 mg/mL in 0.625 mL, 1.25 mL, 2.5 mL, 5.0 mL, 10.0 mL | Injection, Ampoule | Gruppo Lepetit SpA., Anagni (Frosinone), Italy | Anzemet
Citric acid monohydrate 0.07% w/v in 50 mL, 250 mL | Diluent, bottle | McGaw Biomed Limited, Point Chevalier, Auckland | Citric Acid
Dextromethorphan hydrobromide 0.75 mg/mL, paracetamol 50 mg/mL, promethazine hydrochloride 1 mg/mL in 20 mL | Solution, oral | Wrafton Laboratories Limited, Wrafton, Braunton, North Devon, England | Coldrex Night Relief